LexDanaLexDanabeta
Inventor

Minggang FANG

Inventor
US

Overview

3→
Patents
2023–2025
Patent span
Chemistry
Primary field (CPC C)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
C12NMicroorganisms or enzymes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
C07KPeptides9%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms9%
C12YEnzymes9%
PatentTitleYear
12,281,308Inhibition of protein kinases to treat Friedreich ataxia202511,873,494Genetic and pharmacological transcriptional upregulation of the repressed FXN gene as a therapeutic strategy for Friedreich ataxia202411,819,554Compositions and methods for modulating FMR1 expression2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2025Patents assigned to UNIV MASSACHUSETTS (3)· patent assignee history
2023Patents assigned to FULCRUM THERAPEUTICS INC (1)· patent assignee history
2023–2025Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV MASSACHUSETTS32023–2025
FULCRUM THERAPEUTICS INC12023
Locations
LocationPatentsSpan
US32023–2025